Legal Cannabis Market Report Scope & Overview:
The legal cannabis market size was valued at USD 22.16 billion in 2024 and is expected to reach USD 138.08 billion by 2032, growing at a CAGR of 25.75% over the forecast period of 2025-2032.
The global legal cannabis market is growing robustly due to normalization and the increasing legalization for both medical and recreational purposes. From the therapeutic value acknowledged by governments to shifting societal attitudes and an expansion of R&D, providing further opportunities for new applications. Technological developments on the cultivation and processing side, along with high investor interest, are helping to stimulate market development even further. The growth of cannabis derivatives in food, beverage, and pharmaceutical sectors is further catalyzing market uptake in mature and developing economies.
The U.S. legal cannabis market size was valued at USD 29.15 billion in 2024 and is expected to reach USD 144.15 billion by 2032, growing at a CAGR of 22.15% over the forecast period of 2025-2032.
The legal cannabis market in North America is driven by the U.S., with nearly two-thirds of states allowing some form of medicinal or recreational use. The broad demand by consumers, vigorous investment activity, and increasing number of licensed dispensaries are also cementing its leadership status in the region.
Cannabis sales across the U.S. exceeded USD 2billion in 2024, with Illinois leading the way, making it a record year for the state with forecasted tax revenue exceeding USD 490 million, and both statistics proving the strong economic returns from legalization programs.
Market Dynamics:
Drivers
-
Increasing Legalization in Countries is Fueling the Market Expansion
One of the key drivers for the legal cannabis market growth is the gradual legalization of cannabis for medical and recreational purposes. Several, including the U.S. or Canada, Uruguay, and Germany, among others, have created laws to legalize and tax the sale of cannabis. Such a transition does not just broaden the customer reach, but also provides legitimacy to the sector, which helps in translating that enterprise on a large scale, strengthening the supply chain and retail infrastructure. The legal frameworks, which have been making people less dependent on the black market, have finally allowed licensed players to benefit from more revenue.
Furthermore, it encourages knowledgeable use, responsible consumption, and quality regulation. With improving sentiment coverage, more jurisdictions will likely get on board, which will continue to drive market growth.
A ScienceDirect study shows that in the five years after Canada legalized recreational cannabis, the legal market reached about 78% of total cannabis sales within Canada, with dried flower (marijuana) making up nearly 60% of legal cannabis purchases.
Liberals liked that liberalisation allowed the underground market's grip to loosen, provided several billion euros in tax income, but grew only slightly in total usage of all kinds of channels, even more.
-
Product Innovation and Broadband Devices are Driving the Market Growth
Cannabis is a product that gets taken in various ways, and cannabis companies are innovating on the ways by which cannabis is consumed in innovative ways, which are beyond smoking in traditional ways. Different types of goods are being produced by different brands including THC- or CBD-infused beverages, chocolates, gums, skin-care products, and even wellness supplements. The ability to diversify the product offering, often with a well-established brand identity and aesthetically sustainable packaging, attracts health-conscious, curious, and overall lifestyle consumers, allowing businesses to access mainstream markets and grow their clientele.
This type of innovation also allows for micro-dosing and precision formulations, opening cannabis up to neophytes and medical patients alike. This evolution is changing the way consumers expect to interact with and adopt new products.
For instance, Curaleaf introduced Select FormulaX, an energy drink from hemp-derived THC blended with caffeine and cannabinoids, extending into this new beverage category (functional beverage category extension) while also offering a new format of a drinkable product (format innovation).
Restraints:
-
Market Growth is Restrained Due to Regulatory and Legal Uncertainties
Over the years, many countries and U.S. states have legalized medicinal and recreational cannabis, yet a patchwork of inconsistent federal laws still exists, resulting in a chaotic regulatory regime. Cannabis has been illegal at the federal level in the U.S. since the 1970s under the Controlled Substances Act and is classified here as a Schedule I drug, even though many states have legalized it for medical or recreational use. This paradox makes it impossible for cannabis businesses to avail of basic banking, insurance, and commerce across state lines.
In addition, multiple changes in policy of legalization, suspension of licenses, and contentious policies in developing markets of Germany, Thailand, and some regions in Latin America provide additional ambiguity. Approval timelines are protracted, rules change unexpectedly, compliance costs are high, all of which discourage investment and inhibit expansion efforts.
Segmentation Analysis:
By Source
The marijuana segment dominated the legal cannabis market share by source in 2024, with a 76.4% due to its extensive use in medicinal and recreational purposes. The elevated levels of psychoactive compounds, especially THC, available in marijuana mean it is better suited for chronic pain, anxiety, neurological disorders, and adult use in areas where recreational cannabis is permitted. Mature regulatory frameworks in North America and some regions in Europe have additionally enhanced cannabis dispensaries, product options, and patient access programs to a dominant position of market share.
The hemp segment is expected to be the significantly growing over the forecast period in the forecast period, due to the rising demand for cannabidiol (CBD) based wellness and therapeutic products. Due to hemp-derived CBD being non-intoxicating, it is especially interesting for a wider audience in the fields of cosmetics, nutraceuticals, and pharmaceuticals. Decreasing THC levels in various nations have also established greater tolerance by global regulatory authorities, which are facilitating an opening of international hemp-growing markets in developing countries across Asia Pacific, Latin America, and parts of Europe.
By Product Type
Due to holistic use and coping strategies, the flowers/buds segment dominated the legal cannabis market in 2024. This segment serves up cannabis in its most raw, unrefined state, and is a favorite for recreational users and patients who prefer an immediate route through inhalation. Lower production costs and more straightforward access to dried flowers enabled them to be readily available in most legal dispensaries, particularly in mature markets such as the U.S. and Canada.
The fastest growth during the forecast period is expected for the edibles segment, including gummies, baked goods, and beverages, fueled by the shift from smoking to cleaner consumption methods, oil dosing, and long-lasting effects. New Users and wellness-focused consumers favor edibles, their easier lifestyle and range of flavors. Favorable developments, including the advent of new product formulations and the penetration of food & beverage players into the cannabis space, further fuel the growth of this segment globally.
By Derivative
The widespread use in wellness & therapeutics, nutraceuticals, cosmetics, and pharmaceuticals was one of the key factors that significantly increased the total CBD derivative segment and led to dominance over other derivatives in the legal cannabis market in 2024. The absence of psychoactive effects in CBD allows to gain higher acceptance in more populous consumer groups, such as older patients, novices, and those who just want medical benefits but not a high. Additionally, the low regulation in the majority of the nations, more so in Europe and North America, allowed the CBD-infused products to spread across all retail channels, thus further encouraging the segment leading the industry.
The THC segment is estimated to witness the highest growth during the forecast period due to the rise across major markets in the legalization of recreational cannabis, including Germany, Mexico, and several U.S. states. Products with THC produce euphoric properties while having psychoactive effects; this makes them popular in the recreational sector. The ability to develop high-demand offerings derived from THC, combined with constant refinement of formulation technologies, such as nanoemulsion and controlled dosing, and experienced consumers seeking cannabis products with a higher effects profile, will boost their demand globally.
By End-use
The medical use segment held the largest share in 2024 of the legal cannabis market, driven by the acceptance of cannabis as an effective treatment for chronic pain, epilepsy, multiple sclerosis, anxiety, and nausea caused by chemotherapy. Countries, such as Canada, Germany, and multiple states in the U.S. have regulated markets with medical cannabis programs already in place that provide for access via prescription and for physician-driven implementation. The growing ageing population and also the sector clinical research validating the efficiency of cannabis have continued to support market leadership for the medical cannabis segment.
The recreational use segment is projected to grow the fastest during the forecast period, owing to the rapidly rising legalization of cannabis for adult use in North America and a few European and Latin American countries. The normalization of cannabis consumption in lifestyle and wellness contexts and the deployment of the new retail paradigm of dispensaries have broadened the consumer demographic to include those who may not have used cannabis previously. Furthermore, the growing popularity of products, such as edibles, beverages, and vapes is bringing in new young consumers, causing this segment to expand at an unprecedented pace.
Regional Analysis:
Early and broad legalization in major U.S. and Canadian markets drive North America’s dominance in the legal cannabis market trend with a 48.3% market share. While Canada legalized cannabis fully in 2018, the U.S. states have moved forward with progressive cannabis legislation, creating massive cultivation, product innovation, and retail infrastructure. This region is the global leader in the cannabis market and its commercialization, due to favorable regulatory frameworks, increasing medical applications, high consumer awareness, and significant investments from the public and private sectors.
The legal cannabis market in Asia Pacific is growing at the fastest pace, with around 26.34% CAGR over the forecast period, with countries, such as Thailand, South Korea, and Australia working toward the legalization of medical cannabis use. Increasing knowledge regarding therapeutic advantages, continued regulatory changes, and the growth of domestic agricultural production are bolstering the industry. Genuine climatic conditions for the development of cannabis and rising foreign investments for R&D and infrastructure facilities are also spurring cannabis-based products’ adoption and making Asia Pacific the fastest-growing regional market.
The legal cannabis market analysis in Europe is growing due to increased medical cannabis programs, changing regulations, and greater acceptance by patients. With some level of adulthood for medical cannabis systems and rising prescription numbers, Germany, the U.K., and the Netherlands have taken the lead. The region boasts a solid pharmaceutical infrastructure and research programs dedicated to developing therapies with cannabinoids. While the harmonization of regulatory rules is already taking place within the EU, Europe is likely to become one of the best markets for legal cannabis in the forecast years.
The legal cannabis market in Latin America and the Middle East & Africa (MEA) demonstrates moderate growth. In Latin America, nations, such as Colombia and Uruguay have created medical (and some even recreational) cannabis legalities supporting production and exports. But the growth is slower due to regulatory inconsistencies and a lack of aggregated domestic consumption.
Moderate growth in the MEA region is expected owing to regulatory environments becoming gradually stricter in some areas and the cultural sentiment in some other areas. However, their respective mature awareness of the therapeutic attributes of cannabis and early-stage policy processes in South Africa and Israel is setting up the next phase of market growth.
Key Players:
The legal cannabis market companies are Canopy Growth Corporation, Aurora Cannabis Inc., Tilray Brands, Inc., Cronos Group Inc., Curaleaf Holdings, Inc., Trulieve Cannabis Corp., Green Thumb Industries (GTI), Cresco Labs, Aphria Inc., Ayr Wellness Inc., Hexo Corp., Columbia Care Inc., MedMen Enterprises Inc., Organigram Holdings Inc., Sundial Growers Inc., TerrAscend Corp., Vireo Health International, Inc., Harvest Health & Recreation Inc., Jushi Holdings Inc., Village Farms International, Inc., and other players.
Recent Developments:
-
April 2025 – Aurora Cannabis Inc., a top Canadian-based international medical cannabis firm, reported the successful completion of a multi-year $3 million investment to modernize its production plant based in Pemberton, British Columbia. The improvements are intended to streamline production and enhance the company's long-term success in the medical cannabis industry.
-
June 2025 – Tilray Medical, the medical subsidiary of Tilray Brands, Inc., and a worldwide cannabis medical leader, published a new scientific paper. The study compares bioavailability among different cannabinoid formulations, furthering clinical knowledge and enabling informed, individualized treatment choices between physicians and patients.
Report Attributes Details Market Size in 2024 USD 22.16 Billion Market Size by 2032 USD 138.08 Billion CAGR CAGR of 25.75% From 2025 to 2032 Base Year 2024 Forecast Period 2025-2032 Historical Data 2021-2023 Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook Key Segments • By Source (Marijuana, Hemp)
• By Product Type (Flowers/Buds, Oils, Tinctures, Edibles [Gummies, Baked Goods, Beverages], Topicals [Creams, Balms, Lotions], Capsules and Tablets, Concentrates [Waxes, Shatter, Rosin], Others [Transdermal Patches, Suppositories])
• By Derivative (CBD, THC)
• By End-use (Medical Use, Recreational Use, Industrial Use, Veterinarians [Cannabis Products for Animals])Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Company Profiles The legal cannabis market companies are Canopy Growth Corporation, Aurora Cannabis Inc., Tilray Brands, Inc., Cronos Group Inc., Curaleaf Holdings, Inc., Trulieve Cannabis Corp., Green Thumb Industries (GTI), Cresco Labs, Aphria Inc., Ayr Wellness Inc., Hexo Corp., Columbia Care Inc., MedMen Enterprises Inc., Organigram Holdings Inc., Sundial Growers Inc., TerrAscend Corp., Vireo Health International, Inc., Harvest Health & Recreation Inc., Jushi Holdings Inc., Village Farms International, Inc., and other players.
Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Source
2.3.2 Market Size By Product Type
2.3.2 Market Size By Derivative
2.3.2 Market Size By End-Use
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Incidence & Prevalence of Cannabis Use (2024)
4.1.1 Adult cannabis use prevalence, by region (medical vs. recreational)
4.1.2 First-time cannabis user rates and usage frequency
4.1.3 Prevalence of cannabis use disorder (CUD) or dependency
4.1.4 Age-based usage trends: Pediatric, Adult, and Geriatric Segments
4.2 Prescription & Product Access Trends, by Region (2024)
4.2.1 Number of cannabis prescriptions issued by country/region
4.2.2 Most prescribed indications (pain, epilepsy, PTSD, anxiety, etc.)
4.2.3 Medical cardholder penetration rates across legal medical markets
4.2.4 Trends in patient enrollment in state-regulated cannabis programs
4.3 Cannabis Product Sales Volume, by Region and Product Type (2020–2032)
4.3.1 Sales volume by product type (Flowers, Edibles, Oils, Topicals, etc.)
4.3.2 Volume comparison between marijuana-derived and hemp-derived products
4.3.3 Regional sales volume growth trends (North America, Europe, APAC, etc.)
4.3.4 Product substitution trends (e.g., shift from smoking to edibles/vaping)
4.4 Consumer Spending on Cannabis, by Region and Payer Type (2024)
4.4.1 Total and per capita cannabis expenditure, by country/region
4.4.2 Spending by payer type:
4.4.2.1 Out-of-Pocket (Retail/Recreational purchases)
4.4.2.2 Private Insurance (where applicable, e.g., Germany, Israel)
4.4.2.3 Government-Sponsored Reimbursement Programs (e.g., Canada Veterans Affairs)
4.4.3 Average transaction size and frequency across dispensaries
4.4.4 E-commerce vs. in-store purchase behavior and trends
5. Legal Cannabis Market Segmental Analysis & Forecast, By Source, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Marijuana
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Hemp
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.3.3 Hemp CBD
5.3.3.1 Key Trends
5.3.3.2 Market Size & Forecast, 2021 – 2032
5.3.4 Supplements
5.3.4.1 Key Trends
5.3.4.2 Market Size & Forecast, 2021 – 2032
5.3.4 Industrial Hemp
5.3.4.1 Key Trends
5.3.4.2 Market Size & Forecast, 2021 – 2032
6. Legal Cannabis Market Segmental Analysis & Forecast, By Product Type, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Flowers/Buds
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Oils
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Tinctures
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
6.5 Edibles
6.5.1 Key Trends
6.5.2 Market Size & Forecast, 2021 – 2032
6.6 Topicals
6.6.1 Key Trends
6.6.2 Market Size & Forecast, 2021 – 2032
6.7 Capsules and Tablets
6.7.1 Key Trends
6.7.2 Market Size & Forecast, 2021 – 2032
6.8 Concentrates
6.8.1 Key Trends
6.8.2 Market Size & Forecast, 2021 – 2032
6.9 Others
6.9.1 Key Trends
6.9.2 Market Size & Forecast, 2021 – 2032
7. Legal Cannabis Market Segmental Analysis & Forecast, By Derivative, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 CBD
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 THC
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
8. Legal Cannabis Market Segmental Analysis & Forecast, By End-Use, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Medical Use
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.2.3 Cancer
8.2.3.1 Key Trends
8.2.3.2 Market Size & Forecast, 2021 – 2032
8.2.4 Chronic Pain
8.2.4.1 Key Trends
8.2.4.2 Market Size & Forecast, 2021 – 2032
8.2.5 Depression and Anxiety
8.2.5.1 Key Trends
8.2.5.2 Market Size & Forecast, 2021 – 2032
8.2.6 Arthritis
8.2.6.1 Key Trends
8.2.6.2 Market Size & Forecast, 2021 – 2032
8.2.7 Diabetes
8.2.7.1 Key Trends
8.2.7.2 Market Size & Forecast, 2021 – 2032
8.2.8 Glaucoma
8.2.8.1 Key Trends
8.2.8.2 Market Size & Forecast, 2021 – 2032
8.2.9 Migraines
8.2.9.1 Key Trends
8.2.9.2 Market Size & Forecast, 2021 – 2032
8.2.10 Epilepsy
8.2.10.1 Key Trends
8.2.10.2 Market Size & Forecast, 2021 – 2032
8.2.11 Multiple Sclerosis
8.2.11.1 Key Trends
8.2.11.2 Market Size & Forecast, 2021 – 2032
8.2.12 AIDS
8.2.12.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.2.13 Amyotrophic Lateral Sclerosis
8.2.13.1 Key Trends
8.2.13.2 Market Size & Forecast, 2021 – 2032
8.2.14 Alzheimer’s
8.2.14.1 Key Trends
8.2.14.2 Market Size & Forecast, 2021 – 2032
8.2.15 Post-Traumatic Stress Disorder (PTSD)
8.2.15.1 Key Trends
8.2.15.2 Market Size & Forecast, 2021 – 2032
8.2.16 Parkinson's
8.2.16.1 Key Trends
8.2.16.2 Market Size & Forecast, 2021 – 2032
8.2.17 Tourette’s
8.2.17.1 Key Trends
8.2.17.2 Market Size & Forecast, 2021 – 2032
8.2.18 Others
8.2.18.1 Key Trends
8.2.18.2 Market Size & Forecast, 2021 – 2032
8.3 Recreational Use
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Industrial Use
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
8.5 Veterinarians (Cannabis products for animals)
8.5.1 Key Trends
8.5.2 Market Size & Forecast, 2021 – 2032
9. Legal Cannabis Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.2.3 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.2.4 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.2.5 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.2.6 Legal Cannabis Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.2.6.1.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.2.6.1.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.2.6.1.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.2.6.2.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.2.6.2.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.2.6.2.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.3.3 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.3.4 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.3.5 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6 Legal Cannabis Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.3.6.1.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.1.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.3.6.1.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.3.6.2.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.2.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.3.6.2.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.3.6.3.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.3.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.3.6.3.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.3.6.4.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.4.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.3.6.4.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.3.6.5.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.5.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.3.6.5.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.3.6.6.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.6.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.3.6.6.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.3.6.7.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.7.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.3.6.7.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.3.6.8.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.8.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.3.6.8.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.4.3 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.4.4 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.4.5 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6 Legal Cannabis Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.4.6.1.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.1.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.4.6.1.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.4.6.2.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.2.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.4.6.2.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.4.6.3.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.3.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.4.6.3.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.4.6.4.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.4.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.4.6.4.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.4.6.5.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.5.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.4.6.5.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.4.6.6.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.6.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.4.6.6.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.4.6.7.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.7.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.4.6.7.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.5.3 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.5.4 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.5.5 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.5.6 Legal Cannabis Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.5.6.1.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.1.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.5.6.1.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.5.6.2.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.2.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.5.6.2.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.5.6.3.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.3.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.5.6.3.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.5.6.4.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.4.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.5.6.4.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.5.6.5.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.5.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.5.6.5.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.6.3 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.6.4 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.6.5 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.6.6 Legal Cannabis Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.6.6.1.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.1.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.6.6.1.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.6.6.2.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.2.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.6.6.2.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.6.6.3.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.3.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.6.6.3.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.6.6.4.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.4.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.6.6.4.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.6.6.5.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.5.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.6.6.5.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Legal Cannabis Market Size & Forecast, By Source, 2021 – 2032
9.6.6.6.2 Legal Cannabis Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.6.3 Legal Cannabis Market Size & Forecast, By Derivative, 2021 – 2032
9.6.6.6.4 Legal Cannabis Market Size & Forecast, By End Use, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 Canopy Growth Corporation
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Aurora Cannabis Inc.
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 Tilray Brands, Inc.
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Cronos Group Inc.
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Curaleaf Holdings, Inc.
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Trulieve Cannabis Corp.
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Green Thumb Industries (GTI)
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 Cresco Labs
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Aphria Inc.
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Ayr Wellness Inc.
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Hexo Corp.
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Columbia Care Inc.
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 MedMen Enterprises Inc.
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 Organigram Holdings Inc.
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Sundial Growers Inc.
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 TerrAscend Corp.
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Vireo Health International, Inc.
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 Harvest Health & Recreation Inc.
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 Jushi Holdings Inc.
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Village Farms International, Inc.
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Key Segments:
By Source
-
- Marijuana
- Hemp
- Hemp CBD
- Supplements
- Industrial Hemp
By Product Type
- Flowers/Buds
- Oils
- Tinctures
- Edibles (Gummies, Baked Goods, Beverages, etc.)
- Topicals (Creams, Balms, Lotions)
- Capsules and Tablets
- Concentrates (Waxes, Shatter, Rosin)
- Others (Transdermal Patches, Suppositories)
By Derivative
-
- CBD
- THC
By End-Use
-
- Medical Use
- Cancer
- Chronic Pain
- Depression and Anxiety
- Arthritis
- Diabetes
- Glaucoma
- Migraines
- Epilepsy
- Multiple Sclerosis
- AIDS
- Amyotrophic Lateral Sclerosis
- Alzheimer’s
- Post-Traumatic Stress Disorder (PTSD)
- Parkinson's
- Tourette’s
- Others
- Recreational Use
- Industrial Use
- Veterinarians (Cannabis products for animals)
- Medical Use
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- ASEAN Countries
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- Egypt
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
